We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
(-17%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 18.25% |
| 3 | Consumer Discretionary | 14.02% |
| 4 | Industrials | 10.23% |
| 5 | Financials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
TTEC Holdings
TTEC
$124M
| $355K | ﹤0.01% |
12,439
-6,397
| -34% | -$170K |
|
|
EXTN
1902
DELISTED
Exterran Corporation
EXTN
| $355K | ﹤0.01% |
20,041
-37,813
| -65% | -$848K |
|
1903
Alaska Air
ALK
$5.58B
| $354K | ﹤0.01% |
5,819
+1,084
| +23% | +$70.1K |
|
1904
RPM International
RPM
$15B
| $353K | ﹤0.01% |
+6,009
| New | +$368K |
|
1905
Gentherm
THRM
$1.27B
| $352K | ﹤0.01% |
+8,804
| New | +$373K |
|
|
PVLA
1906
Palvella Therapeutics
PVLA
$2.27B
| $352K | ﹤0.01% |
1,654
-77
| -4% | -$23.9K |
|
1907
Eagle Bancorp
EGBN
$845M
| $351K | ﹤0.01% |
7,197
-90,321
| -93% | -$4.6M |
|
1908
Mativ Holdings
MATV
$711M
| $351K | ﹤0.01% |
14,002
+36
| +0.3% | +$1.11K |
|
|
PGTI
1909
DELISTED
PGT, Inc.
PGTI
| $351K | ﹤0.01% |
22,151
-143,958
| -87% | -$2.78M |
|
|
RAVN
1910
DELISTED
Raven Industries Inc
RAVN
| $351K | ﹤0.01% |
9,701
+2,894
| +43% | +$120K |
|
|
MEET
1911
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $351K | ﹤0.01% |
75,753
+9,399
| +14% | +$40.1K |
|
|
BPYU
1912
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $350K | ﹤0.01% |
21,739
-5,193
| -19% | -$94.8K |
|
|
ISCA
1913
DELISTED
International Speedway Corp
ISCA
| $347K | ﹤0.01% |
7,918
-34,211
| -81% | -$1.38M |
|
1914
CryoPort
CYRX
$762M
| $346K | ﹤0.01% |
31,388
-4,788
| -13% | -$52K |
|
1915
Tompkins Financial
TMP
$1.42B
| $346K | ﹤0.01% |
4,613
-2,688
| -37% | -$206K |
|
1916
Houlihan Lokey
HLI
$9.02B
| $345K | ﹤0.01% |
9,383
-17,600
| -65% | -$717K |
|
1917
RBC Bearings
RBC
$18B
| $344K | ﹤0.01% |
2,626
-2,070
| -44% | -$301K |
|
|
GBT
1918
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $344K | ﹤0.01% |
8,390
-11,416
| -58% | -$428K |
|
1919
Rithm Capital
RITM
$5.69B
| $343K | ﹤0.01% |
24,172
-36,612
| -60% | -$619K |
|
|
EBSB
1920
DELISTED
Meridian Bancorp, Inc.
EBSB
| $343K | ﹤0.01% |
23,971
-35,925
| -60% | -$566K |
|
1921
MacroGenics
MGNX
$257M
| $342K | ﹤0.01% |
+26,938
| New | +$452K |
|
1922
Ultragenyx Pharmaceutical
RARE
$2.55B
| $342K | ﹤0.01% |
7,858
+976
| +14% | +$53.3K |
|
|
BNCL
1923
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $342K | ﹤0.01% |
23,960
-121
| -0.5% | -$1.88K |
|
|
VRTV
1924
DELISTED
VERITIV CORPORATION
VRTV
| $341K | ﹤0.01% |
+13,658
| New | +$415K |
|
1925
Axogen
AXGN
$2.5B
| $340K | ﹤0.01% |
16,639
-46,839
| -74% | -$1.47M |
|
Similar funds
VGA
AQR Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
- AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
- AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.